Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 173
Gene Symbol: AFM
AFM
0.010 AlteredExpression disease BEFREE As a result, compared to the menopause and healthy fertile groups, eleven proteins, including Neurturin, Frizzled-5, Serpin D1, MMP-7, ICAM-3, IL-17F, IFN-gamma R1, IL-29, IL-17R, IL-17C and Soggy-1, were uniquely down-regulated, and Afamin was particularly up-regulated in POI serum. 31629109 2020
Entrez Id: 657
Gene Symbol: BMPR1A
BMPR1A
0.010 Biomarker disease BEFREE We consider that BMPR1A and BMPR1B variants constitute genetic biomarkers of POI´s origin with clinical utility. 31769494 2020
Entrez Id: 658
Gene Symbol: BMPR1B
BMPR1B
0.010 Biomarker disease BEFREE We consider that BMPR1A and BMPR1B variants constitute genetic biomarkers of POI´s origin with clinical utility. 31769494 2020
Entrez Id: 23438
Gene Symbol: HARS2
HARS2
0.010 GeneticVariation disease BEFREE Biallelic variants in HARS2 are associated with Perrault syndrome, a rare recessive condition characterized by sensorineural hearing loss in both sexes and primary ovarian insufficiency in 46,XX females. 31827252 2020
Entrez Id: 3162
Gene Symbol: HMOX1
HMOX1
0.010 AlteredExpression disease BEFREE Hemin but not DMF caused a significant increase in intestinal HO-1 protein expression and co-administration of the HO-1 inhibitor chromium mesoporphyrin abolished the protective effects of hemin on POI; DMF reduced the IM-induced activation of NF-κB and ERK 1/2. 31121086 2020
Entrez Id: 9874
Gene Symbol: TLK1
TLK1
0.010 Biomarker disease BEFREE Tousled like kinase 1 (<i>TLK1</i>), a member of DNA repair family, participates in the regulation of chromatin assembly and is associated with early menopause and premature ovarian insufficiency (POI) in European women. 31362519 2020
Entrez Id: 27120
Gene Symbol: DKKL1
DKKL1
0.010 AlteredExpression disease BEFREE As a result, compared to the menopause and healthy fertile groups, eleven proteins, including Neurturin, Frizzled-5, Serpin D1, MMP-7, ICAM-3, IL-17F, IFN-gamma R1, IL-29, IL-17R, IL-17C and Soggy-1, were uniquely down-regulated, and Afamin was particularly up-regulated in POI serum. 31629109 2020
Entrez Id: 5595
Gene Symbol: MAPK3
MAPK3
0.010 AlteredExpression disease BEFREE Hemin but not DMF caused a significant increase in intestinal HO-1 protein expression and co-administration of the HO-1 inhibitor chromium mesoporphyrin abolished the protective effects of hemin on POI; DMF reduced the IM-induced activation of NF-κB and ERK 1/2. 31121086 2020
Entrez Id: 4853
Gene Symbol: NOTCH2
NOTCH2
0.010 GeneticVariation disease BEFREE The results have demonstrated for the first time that NOTCH2 mutations contribute to POI etiology. 30304577 2019
Entrez Id: 171568
Gene Symbol: POLR3H
POLR3H
0.010 GeneticVariation disease BEFREE Screening of the POLR3H gene may elucidate POI cases without previously identified genetic causes, supporting approaches of genetic counseling. 30830215 2019
Entrez Id: 645682
Gene Symbol: POU5F1P4
POU5F1P4
0.010 AlteredExpression disease BEFREE The results show that the activity of Hh signaling is decreased in the ovaries in physiological aging and POF models, which is consistent with the trend of expression levels of the germline stem cell markers Mvh and Oct4. 31277696 2019
Entrez Id: 407014
Gene Symbol: MIR25
MIR25
0.010 GeneticVariation disease BEFREE The haplotype-based multifactor dimensionality reduction analysis revealed that the T-C-T-G (miR-25/-32/-125/-222), T-A-C-G (miR-25/-32/-125/-222), C-T-G (miR-32/-125/-222), A-C-G (miR-32/-125/-222), T-G (miR-122/-222), C-T (miR-32/-125), and C-C (miR-25/-32) inferred haplotypes were significantly less frequent in POI (P < 0.05), which suggested potential protective effects. 30422934 2019
Entrez Id: 283
Gene Symbol: ANG
ANG
0.010 Biomarker disease BEFREE The expression levels of total AKT, p-AKT, and angiogenic cytokines (including VEGF, IGF, and angiogenin) in the ovaries of POI mice were markedly upregulated after HUCMSC-MVs transplantation, suggesting that HUCMSC-MVs transplantation might recover ovarian function by inducing angiogenesis via the PI3K/AKT signaling pathway. 31412919 2019
Entrez Id: 79065
Gene Symbol: ATG9A
ATG9A
0.010 GeneticVariation disease BEFREE We venture a functional link between ATG7 and ATG9A variants and POI. 30224786 2019
Entrez Id: 983
Gene Symbol: CDK1
CDK1
0.010 AlteredExpression disease BEFREE MB-MSCs combined with BSTCR improved the ovarian function of epirubicin induced POF mice, which might be related to the inhibition of GADD45b expression and the promotion of CyclinB1 and CDC2 expressions. 31311554 2019
Entrez Id: 2081
Gene Symbol: ERN1
ERN1
0.010 AlteredExpression disease BEFREE And the IRE1α pathway was activated in ovaries of POF mice, as demonstrated by, increased X-box binding protein 1 (XBP1), up-regulated 78 kDa glucose-regulated protein (GRP78) and caspase-12. 31081266 2019
Entrez Id: 7077
Gene Symbol: TIMP2
TIMP2
0.010 GeneticVariation disease BEFREE Our data suggest that the minor TIMP2 alleles may increase POI risk in Korean women. 30583769 2019
Entrez Id: 9447
Gene Symbol: AIM2
AIM2
0.010 Biomarker disease BEFREE Mouse strains deficient in inflammasome formation identified the absent in melanoma 2 (AIM2) inflammasome to be crucial for IL-1β production in POI. 31332247 2019
Entrez Id: 406949
Gene Symbol: MIR15B
MIR15B
0.010 AlteredExpression disease BEFREE It elucidated the underlying epigenetic regulatory mechanism, whereby cyclophosphamide-dependent microRNA-15b inhibited Kl expression, leading to the reduced ability of mOGCs to induce autophagy and ROS scavenging, ultimately causing POF. 31310795 2019
Entrez Id: 60674
Gene Symbol: GAS5
GAS5
0.010 Biomarker disease BEFREE It also suggested that the GAS5/miR-21a axis may be a potential therapeutic target for premature ovarian failure in the clinic. 31319247 2019
Entrez Id: 1678
Gene Symbol: TIMM8A
TIMM8A
0.010 Biomarker disease BEFREE Women of reproductive age treated with DDP may lead to loss of primordial follicles, resulting in the depletion of the ovarian reserve and consequent premature ovarian failure. 31301169 2019
Entrez Id: 706
Gene Symbol: TSPO
TSPO
0.010 Biomarker disease BEFREE Thirty adult female rats were randomly subdivided into five groups: normal control (control), cyclophosphamide (CTX) plus subsequent PBS (POI + PBS), CTX plus subsequent PRP (POI + PRP), CTX plus subsequent G-CSF-mobilized PBMCs (POI + PBMCs), and CTX plus subsequent G-CSF-mobilized PBMCs combined with PRP (POI + PBMCs + PRP). 31034039 2019
Entrez Id: 967
Gene Symbol: CD63
CD63
0.010 Biomarker disease BEFREE This study aimed to identify exosomes derived from hAECs and explored the therapeutic potential in ovaries damaged by chemotherapy and the underlying molecular mechanism. hAEC-derived exosomes exhibited a cup- or sphere-shaped morphology with a mean diameter of 100 nm and were positive for Alix, CD63, and CD9. hAEC exosomes increased the number of follicles and improved ovarian function in POF mice. 31022607 2019
Entrez Id: 7076
Gene Symbol: TIMP1
TIMP1
0.010 GeneticVariation disease BEFREE Association between tissue inhibitor of metalloproteinase (TIMP) genetic polymorphisms and primary ovarian insufficiency (POI). 30583769 2019
Entrez Id: 407036
Gene Symbol: MIR32
MIR32
0.010 AlteredExpression disease BEFREE Participants with POI had significantly increased luteinizing hormone levels (P < 0.05), but hormonal levels, including luteinizing hormone, were not significantly different between POI women and control women with miR-32/-125/-222. 30422934 2019